Table 1.
HSPC receptor
|
Bone marrow ligands
|
Effect
|
Ref.
|
PSGL-1/CD162 | Selectins (P and E) | Promote HSPC homing | [10] |
β1 integrin | Opn | Contribute to HSC trans-marrow migration toward the endosteal region | [17,18] |
VLA-4/α4 β1 | VCAM-1, fibronectin | Promote HSPC homing | [7,11] |
VLA-5/α5 β1 | Fibronectin | Promote HSPC homing and proliferation | [19,20] |
LFA-1/αL β2 | ICAM-1 | Promote HSPC homing | [7,11] |
LPAM-1/α4 β7 | MAdCAM-1 | Promote HSPC homing and engraftment | [21] |
Cx43 | Participate in the formation of intercellular transmembrane channels, facilitate the transportation of mitochondria or other substances, and promote bone marrow regeneration and HSPC engraftment | [22] | |
CXCR4 | SDF-1 | Promote HSPC homing and engraftment and participate in the regulation of HSPC survival and proliferation | [7] |
c-kit | SCF | The transmembrane isoform of SCF is critical in the lodgment and detainment of HSCs within the bone marrow niche | [23] |
c-MPL | TPO | TPO promotes the survival and proliferation of HSPCs and upregulates SDF-1 in the bone marrow niche, thereby contributing to HSPC homing and engraftment | [24,25] |
CD44/Pgp-1 | Selectins (P, E and L), HA | CD44 and HA play a key role in SDF-1-dependent transendothelial migration of HSPCs and their final anchorage within the bone marrow niche | [26] |
CD82/KAI1 | CD82 modulates HSPC bone marrow maintenance, homing, and engraftment | [27] | |
Anxa2r | Annexin II/Anxa2 | Regulate stem cell adhesion, homing, and engraftment | [28] |
CaR | Ca2+ | Enhance HSC lodgment and engraftment in the bone marrow niche | [29] |
N-cadherin | N-cadherin | N-cadherin-mediated cell adhesion is functionally required for the establishment of hematopoiesis in the bone marrow niche after bone marrow transplantation | [30] |
Anxa2r: Annexin II receptor; c-kit: Tyrosine-protein kinase kit; c-MPL: Thrombopoietin receptor; Ca2+: Calcium; CaR: Calcium-sensing receptor; CD162: cluster of differentiation 162; CD44: Cluster of differentiation 44; CD82: Cluster of differentiation 82; Cx43: Connexin 43; CXCR4: C-X-C chemokine receptor 4; HA: Hyaluronic acid; HSC: Hematopoietic stem cell; HSPC: Hematopoietic stem and progenitor cells; ICAM-1: Intercellular adhesion molecule 1; KAI1: Kangai 1; LFA-1: Lymphocyte function-associated antigen-1; LPAM-1: Lymphocyte Peyer's patch adhesion molecule-1; MAdCAM-1: Mucosal addressin cell adhesion molecule-1; MPL: Myeloproliferative leukemia gene; Opn: Osteopontin; Pgp-1: Phagocytic glycoprotein-1; PSGL-1: P-selectin glycoprotein ligand-1; Ref.: Reference; SCF: Stem cell factor; SDF-1: Stromal cell-derived factor-1; TPO: Thrombopoietin; VCAM-1: Vascular cellular adhesion molecule-1; VLA-4: Very late antigen 4; VLA-5: Very late antigen 5.